Flash

Latest News

Thu, 10 May 2012 09:00:00 -0400

Impax Laboratories to Present at the Bank of America Merrill Lynch 2012 Health Care Conference

Tue, 01 May 2012 07:00:00 -0400

Impax Laboratories Reports Adjusted First Quarter 2012 EPS of $0.52; GAAP EPS of $0.18

Wed, 18 Apr 2012 08:30:00 -0400

Data from ASCEND-PD Phase III Study of IPX066 to be Presented at the American Academy of Neurology Conference

View All
Pipeline

Pipeline

Utilizing formulation and drug delivery expertise to offer innovative CNS products.

Learn More
Therapeutic Research

Therapeutic Research

One area of focus is improving on current standards of Parkinson’s therapy.

Learn More